Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Claudiu T Supuran. (2023) Targeting carbonic anhydrases for the management of hypoxic metastatic tumors. Expert Opinion on Therapeutic Patents 33:11, pages 701-720.
Read now
Read now
Mohammed A. Assiri, Tarik E. Ali, Maha N. Alqahtani, Ali. A. Shati, Mohammed. Y. Alfaifi & Serag. E. I. Elbehairi. (2023) Synthesis, cytotoxic evaluation, apoptosis, cell cycle, and molecular docking studies of some new 5-(arylidene/heteroarylidene)-2-(morpholinoimino)-3-phenylthiazolidin-4-ones. Synthetic Communications 53:15, pages 1240-1261.
Read now
Read now
Dhakshinamurthy Divya, Venkatesan Srinivasan, Arunachalam Prabakaran, Chandramohan Uma Maheswari, Thamilselvan Rajamani & Sambantham Muthu. Computational, Reactivity, Fukui Function, Molecular Docking, and Spectroscopic Studies of a Novel (E)-1-Benzyl-3-(2-(Pyrindin-2-yl)Hydrazono)Indolin-2-One. Polycyclic Aromatic Compounds 0:0, pages 1-21.
Read now
Read now
Articles from other publishers (9)
Gourav Kumar, Parveen Kumar, Akta Soni, Venu Sharma & Meena Nemiwal. (2024) Efficient synthesis and molecular docking analysis of quinazoline and azole hybrid derivatives as promising agents for anti-cancer and anti-tuberculosis activities. Journal of Molecular Structure 1310, pages 138289.
Crossref
Crossref
Moataz A. Shaldam, Maha-Hamadien Abdulla, Andrea Angeli, Salma M. Hefny, Eman M. El-labbad, Abdullah Bin Obeed, Noura S. Alhassan, Claudiu T. Supuran, Wagdy M. Eldehna & Haytham O. Tawfik. (2024) Novel sulfonamide-tethered Schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: Synthesis, biological assessment, and molecular dynamic simulations. Journal of Molecular Structure 1309, pages 138148.
Crossref
Crossref
Md. Saddam Hossain, Md. Anisur Rahman, Prithbey Raj Dey, Md. Parvez Khandocar, Md. Yeakub Ali, Mahajabin Snigdha, Henrique Douglas Melo Coutinho & Muhammad Torequl Islam. (2024) Natural Isatin Derivatives Against Black Fungus: In Silico Studies. Current Microbiology 81:5.
Crossref
Crossref
Salma M. Hefny, Tarek F. El-Moselhy, Nabaweya El-Din, Simone Giovannuzzi, Thamer Bin Traiki, Mansoor-Ali Vaali-Mohammed, Ahmed M. El-Dessouki, Koki Yamaguchi, Masaharu Sugiura, Moataz A. Shaldam, Claudiu T. Supuran, Maha-Hamadien Abdulla, Wagdy M. Eldehna & Haytham O. Tawfik. (2024)
Discovery and Mechanistic Studies of Dual-Target Hits for Carbonic Anhydrase IX and VEGFR-2 as Potential Agents for Solid Tumors: X-ray,
In Vitro
,
In Vivo
, and
In Silico
Investigations of Coumarin-Based Thiazoles
. Journal of Medicinal Chemistry.
Crossref
Crossref
Alia Mushtaq, Peng Wu & Muhammad Moazzam Naseer. (2024) Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets. Pharmacology & Therapeutics 254, pages 108579.
Crossref
Crossref
Haytham O. Tawfik, Mohamed M. Saleh, Andrea Ammara, Eman F. Khaleel, Rehab Badi, Yomna T. T. Khater, Rabab A. Rasheed, Ahmed A. Attia, Salma M. Hefny, Eslam B. Elkaeed, Alessio Nocentini, Claudiu T. Supuran, Wagdy M. Eldehna & Moataz A. Shaldam. (2024) Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma. Journal of Medicinal Chemistry 67:2, pages 1611-1623.
Crossref
Crossref
Samir Bondock, Tallah Albarqi, Moaz M. Abdou & Nada M. Mohamed. (2023) Computational insights into novel benzenesulfonamide-1,3,4-thiadiazole hybrids as a possible VEGFR-2 inhibitor: design, synthesis and anticancer evaluation with molecular dynamics studies. New Journal of Chemistry 47:44, pages 20602-20618.
Crossref
Crossref
Zainab Kifah Abbas, Noor H. Naser & Rana Neama Atiya. (2023) IN SILICO STUDY OF NOVEL SULFONAMIDE DERIVATIVES BEARING A 1, 2, 4-TRIAZOLE MOIETY ACT AS CARBONIC ANHYDRASE INHIBITORS WITH PROMISING ANTI-CANCER ACTIVITY. Polski Merkuriusz Lekarski 51:5, pages 527-532.
Crossref
Crossref
Ankush KumarBhupinder KumarRohit Bhatia. (2023) Design, Synthesis, Molecular Docking, and Biological Evaluation of Isatin-Based Fused Heterocycles As Epidermal Growth Factor Receptor Inhibitors. ASSAY and Drug Development Technologies 21:5, pages 222-233.
Crossref
Crossref